CAN/CSA-ISO 11737-2-2021
保健产品灭菌 微生物方法 第2部分:在灭菌过程的定义、验证和维护中进行的无菌测试(采用 ISO 11737-2:2019 第三版 2019-12)

Sterilization of health care products - Microbiological methods - Part 2: Tests of sterility performed in the definition, validation and maintenance of a sterilization process (Adopted ISO 11737-2:2019, third edition, 2019-12)


 

 

非常抱歉,我们暂时无法提供预览,您可以试试: 免费下载 CAN/CSA-ISO 11737-2-2021 前三页,或者稍后再访问。

您也可以尝试购买此标准,
点击右侧 “立即购买” 按钮开始采购(由第三方提供)。

 

标准号
CAN/CSA-ISO 11737-2-2021
发布
1970年
发布单位
SCC
当前最新
CAN/CSA-ISO 11737-2-2021
 
 
适用范围
  Full Description Preface: This is the first edition of CSA ISO 11737-2, Sterilization of health care products — Microbiological methods — Part 2: Tests of sterility performed in the definition, validation and maintenance of a sterilization process, which is an adoption without modification of the identically titled ISO (International Organization for Standardization) Standard 11737-2 (third edition, 2019-12). CSA Group acknowledges that the adoption of this Standard was made possible, in part, by the financial support of the governments of Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland and Labrador, Northwest Territories, Nova Scotia, Nunavut, Ontario, Prince Edward Island, Québec, Saskatchewan, and Yukon, as administered by the Canadian Agency for Drugs and Technologies in Health (CADTH). This Standard has been developed in compliance with Standards Council of Canada requirements for National Standards of Canada. It has been published as a National Standard of Canada by CSA Group. Scope: 1.1 This document specifies the general criteria for tests of sterility on medical devices that have been exposed to a treatment with the sterilizing agent which has been reduced relative to that anticipated to be used in routine sterilization processing. These tests are intended to be performed when defining, validating or maintaining a sterilization process. 1.2 This document is not applicable to: a) sterility testing for routine release of product that has been subjected to a sterilization process, b) performing a test for sterility (see 3.12), NOTE 1 The performance of a) or b) is not a requirement of ISO 11135, ISO 11137-1, ISO 11137-2, ISO 14160, ISO 14937, ISO 17665-1 or ISO 20857. c) test of sterility or test for sterility for demonstration of product shelf life, stability and/or package integrity, and d) culturing of biological indicators or inoculated products. NOTE 2 Guidance on culturing biological indicators is included in ISO 11138-7.

CAN/CSA-ISO 11737-2-2021相似标准


推荐

法规解读 | 欧盟最新 《药品、活性物质、辅料内包材灭菌指南》划重点

对于水溶液,表1规定限值适用于原料药制剂,无需进一步说明。规定水平上控制微生物负荷其他测试方法限值应予以说明。表1 蒸汽灭菌无菌后热处理程序以及质量文档要求相应数据干热灭菌• 使用欧洲药典5.1.1(至少160°C,至少2小时)参考条件进行灭菌,不要求质量文档中提交灭菌程序验证数据。...

湿热灭菌方法验证默克Sterikon® plus来帮您

欧美均有对于灭菌工艺验证相关要求[1] : 美国注射剂协会(Parenteral DrugAssociation,PDA)系列技术报告1号《湿热灭菌程序验证:灭菌程序设计、开发、确认及日常监控》、30号《采用湿热灭菌最终灭菌药品及医疗器械参数放行》48号《湿热灭菌设备系统: 设计、试车、运行、确认维护》[7]欧洲EMA于2019年发布了《制剂、原料药、辅料内包材灭菌指南》。...

隔离器环境微生物监测真相及解决方案,你应该知道!

从实验室无菌检测到车间日常生产过程,隔离器技术已经无菌药品检测生产中得到了广泛应用。为什么隔离技术会越来越多应用于制药行业呢?主要是因为隔离器内环境与周围环境是完全隔离,作为独立环境,隔离器可以使无菌生产操作受控环境中进行,保护药品无菌环境免受由于环境操作人员所带来污染风险,最大限度的确保产品安全。...

国家药品监督管理局发布《除菌过滤技术及应用指南》

本指南是基于目前认知与科技水平起草,并不限制新技术与新方法引入。企业可以采用经过验证替代方法,达到本指南要求。  2.定义  本指南中除菌过滤是指采用物理截留方法去除液体或气体微生物,以达到无菌药品相关质量要求过程。  3.范围  本指南包括除菌过滤系统设计、选择、验证、使用等内容,适用于无菌药品从工艺开发到上市生产整个生命周期。  ...





Copyright ©2007-2022 ANTPEDIA, All Rights Reserved
京ICP备07018254号 京公网安备1101085018 电信与信息服务业务经营许可证:京ICP证110310号